Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device company developing and commercializing innovative, interventional treatment systems for vascular and coronary disease, will present at three upcoming conferences: the William Blair Life Sciences Conference at the Intercontinental New York Barclay, the Robert W. Baird Health Care Conference at the New York Palace, and the Sixth Annual JMP Securities Health Care Conference at the St. Regis New York. President and Chief Executive Officer David L. Martin and Chief Financial Officer Laurence L. Betterley will provide an overview of the company and its growth opportunities.
|WHEN:||William Blair Life Sciences Conference|
|Wednesday, Sept. 7; 10:50 a.m. ET|
|Intercontinental New York Barclay|
|Robert W. Baird Health Care Conference|
|[Q&A format, no webcast]|
|Wednesday, Sept. 7; 1:15 p.m. ET|
|The New York Palace|
|Sixth Annual JMP Securities Health Care Conference|
|Tuesday, Sept. 27; 11 a.m. ET|
|St. Regis New York|
|WEBCAST:||To listen to a live webcast of the presentations at the William Blair Life Sciences Conference and Sixth Annual JMP Securities Health Care Conference, go to the investor information section of the company’s Web site, www.csi360.com, and click on the respective webcast icon.|
|If you have any difficulty accessing the webcasts, please contact|
|Mick Forgey: (612) 455-1789; email@example.com|
CSI has also commenced its ORBIT II Investigational Device Exemption clinical trial to evaluate the safety and effectiveness of its orbital technology in treating coronary arteries. The coronary system is limited by federal law to investigational use and is currently not commercially available in the United States.For more information, visit the company’s website at www.csi360.com.